Aspirin Therapy for Colorectal Cancer With PIK3CA Mutation: Simply Complex!

被引：14
|
作者：
Fuchs, Charles S. [1 ]
Ogino, Shuji [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 34期
关键词：
NF-KAPPA-B; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED-TRIAL; BETA-CATENIN; COLON-CANCER; ADENOMAS; PATHWAY; PREVENTION; ACTIVATION; EXPRESSION;
D O I：
10.1200/JCO.2013.52.0080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：4358 / 4361
页数：4
相关论文
共 50 条
  • [31] Aspirin for PIK3CA-mutated colorectal cancer
    Gilbert, Judith A.
    LANCET ONCOLOGY, 2012, 13 (12): : E522 - E522
  • [32] PIK3CA Mutation Detection by Pyrosequencing
    Baker, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 902 - 902
  • [33] Rare mutation of PIK3CA in meningiomas
    Jesse Chung-sean Pang
    Nellie Yuk Fei Chung
    Norman Hok Ling Chan
    Wai Sang Poon
    Teresa Thomas
    Ho-keung Ng
    Acta Neuropathologica, 2006, 111 : 284 - 285
  • [34] Rare mutation of PIK3CA in meningiomas
    Pang, JCS
    Chung, NYF
    Chan, NHL
    Poon, WS
    Thomas, T
    Ng, HK
    ACTA NEUROPATHOLOGICA, 2006, 111 (03) : 284 - 285
  • [35] PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis
    Jin, Juan
    Shi, Yaqin
    Zhang, Shu
    Yang, Shuofei
    ACTA ONCOLOGICA, 2020, 59 (01) : 66 - 74
  • [36] PIK3CA mutation profiling in Vietnamese patients with breast cancer
    Vuong, Linh Dieu
    Ta, To Van
    Chu, Ha Hoang
    Truong, Van-Long
    Nguyen, Quang Ngoc
    META GENE, 2020, 25
  • [37] PIK3CA mutation, aspirin use after diagnosis, and colorectal cancer survival: A systematic review and meta-analysis of epidemiological studies
    Paleari, Laura
    Puntoni, Matteo
    Clavarezza, Matteo
    Caviglia, Silvia
    Corradengo, Davide
    Campazzi, Eleonora
    Provinciali, Nicoletta
    De Censi, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] MTORC1/2 and HDAC1/2 inhibition as therapy for colorectal cancer with PIK3CA mutation
    Olson, Autumn M.
    DeStefanis, Rebecca A.
    DeZeeuw, Alyssa K.
    Payne, Susan N.
    Pasch, Cheri A.
    Clipson, Linda
    Deming, Dustin A.
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
    Domingo, Enric
    Church, David N.
    Sieber, Oliver
    Ramamoorthy, Rajarajan
    Yanagisawa, Yoko
    Johnstone, Elaine
    Davidson, Brian
    Kerr, David J.
    Tomlinson, Ian P. M.
    Midgley, Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4297 - U34
  • [40] PIK3CA Mutation Predicts Poor Prognosis in Stage I-III Colorectal Cancer
    Ogino, S.
    Nosho, K.
    Kirkner, G. J.
    Shima, K.
    Irahara, N.
    Kure, S.
    Chan, A. T.
    Engelman, J. A.
    Kraft, P.
    Cantley, L. C.
    LABORATORY INVESTIGATION, 2009, 89 : 143A - 143A
12345